An emerging science: Nutrigenectics;Une science émergente: La nutrigénétique

Cahiers de Nutrition et de Dietetique

Volumn 37, Issue 6, 2002, Pages 369-386

  Junien, Claudine ^a  

^a NONE

Author keywords

Diabetes; Epigenetics; Gene environment interaction; Nutrigenetics; Obesity; Transgenerational effects

Indexed keywords

AMINO ACID; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; BETA 2 ADRENERGIC RECEPTOR; BLOOD CLOTTING FACTOR 7; CARBOHYDRATE; FATTY ACID; MULTIDRUG RESISTANCE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROL; TRACE ELEMENT;

ENVIRONMENTAL FACTOR; EXERCISE; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; NUTRIGENETICS; NUTRITIONAL SCIENCE; POSTPRANDIAL STATE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 18844477080     PISSN: 00079960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Kaplan M. et al. - Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA, 1997, 94, 12128-32.
2. Lown K. et al. - Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression, J Clin Invest, 1997, 99, 2545-35.
3. Webb G. C., Akbar M. S., Zhao C., Steiner D. F. - Expression profiling of pancreatic beta cells: glucose regulation of secretory and metabolic pathway genes. Proc Natl Acad Sci U S A, 2000, 97, 5773-8.
4. Kita Y. et al. - Implications of circadian gene expression in kidney, liver and the effects of fasting on pharmacogenomic studies. Pharmacogenetics, 2002, 12, 55-65.
5. Hu R. M. et al. - Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci U S A, 2000, 97, 9543-8.
6. Drysdale C. M. et al. - Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A, 2000, 97, 10483-88.
7. Weiss S. T., Silverman E. K., Palmer L. J. - Case-control association studies in pharmacogenetics. Pharmacogenomics J, 2001, 1, 157-8.
8. Wilson J. F. et al. - Population genetic structure of variable drug response. Nat Genet, 2001, 29, 265-9.
9. Perusse L. et al. - The human obesity gene map: the 2000 update. Obes Res, 2001, 9, 135-69.
10. Fournet J. C. et al. - Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol, 2001, 158, 2177-84.
11. Bouchard C., Perusse L. - Current status of the human obesity gene map. Obes Res, 1996, 4, 81-90.
12. Irizarry K., Hu G., Wong M. L., Licinio J., Lee C. J. - Single nucleotide polymorphism identification in candidate gene systems of obesity. Pharmacogenomics J, 2001, 1, 193-203; Rankinen T. et al. - The Human Obesity Gene Map: The 2001 Update. Obes Res, 2002, 10, 196-243.
13. Irizarry K., Hu G., Wong M. L., Licinio J., Lee C. J. - Single nucleotide polymorphism identification in candidate gene systems of obesity. Pharmacogenomics J, 2001, 1, 193-203; Rankinen T. et al. - The Human Obesity Gene Map: The 2001 Update. Obes Res, 2002, 10, 196-243.
14. Cone R. D. - Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype? J Clin Invest, 2000, 106, 185-7.
15. Gütersohn A., Hunold P., Schmermund, A. (ed. Circulation) (2000).
16. Ong K. K., Dunger D. B. - Thrifty genotypes and phenotypes in the pathogenesis of type 2 diabetes mellitus. J Pediatr Endocrinol Metab, 2000, 13, 1419-24.
17. 4 a 'thrifty' allele? Ann Hum Genet, 1999, 63, 301-10.
18. Mori H. et al. - A polymorphism in the 5' untranslated region and a Met229- > Leu variant in exon 5 of the human UCP1 gene are associated with susceptibility to type II diabetes mellitus. Diabetologia, 2001, 44, 373-6.
19. Hara K. et al. - The role of PPARgamma as a thrifty gene both in mice and humans. Br J Nutr, 2000, 84 Suppl 2, S235-239.
20. Sharma A. M. - The thrifty-genotype hypothesis and its implications for the study of complex genetic disorders in man. J Mol Med, 1998, 76, 568-71.
21. Groop L. C. - Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes Obes Metab, 1999, 1 (Suppl 1), S1-7.
22. Lee H. K. - Evidence that the mitochondrial genome is the thrifty genome. Diabetes Res Clin Pract, 1999, 45, 127-35.
23. Schalin-Jantti C. et al. - Polymorphism of the glycogen synthase gene in hypertensive and normotensive subjects. Hypertension, 1996, 27, 67-71.
24. Knoblauch H. et al. - A cholesterol-lowering gene maps to chromosome 13q. Am J Hum Genet, 2000, 66, 157-66.
25. Carmena-Ramon R. et al. - Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and plasma lipoprotein levels in familial hypercholesterolemia. Metabolism, 2001, 50, 651-6.
26. Leus F.R., Zwart M., Kastelein J. J., Voorbij H. A. - PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients. Atherosclerosis, 2001, 154, 641-9.
27. Wierzbicki A. S., Lambert-Hammill M., Junadi E., Lumb P. J., Crook M. A. - Differing relationships of methylene tetrahydrofolate reductase genotypes with cardiovascular risk in familial and polygenic hypercholesterolaemia. J Cardiovasc Risk, 2000, 7, 431-4.
28. Neklason D., Otterud B., Coon H. (ed. Genetics, A. J. o. H.) (2000).
29. Mutanen M., Freese R. - Fats, lipids and blood coagulation. Curr Opin Lipidol, 2001, 12, 25-9.
30. Lopez-Miranda J., Paz E, Marin C, Perez-Martinez P, Gomez P, Bravo D, Ordovas JM, Perez-Jimenez F et al. - in Circulation 18 102 suppt 2 (2000). Lopez-Miranda J, Diet Induced Changes in LDL Particle Size Are Mediated by Variation at the ApoE Locus
31. Lopez-Miranda J., Galluzzi J R, Marin C, Bravo D, Paz E, Gomez P, Perez-Martinez P, Fernandez de la Puebla R A, Ordovas J M, Perez-Jimenez F. - The Ala54thr Polymorphism at the Fatty Acid Binding Protein-2 Locus is Associated with Insulin Sensitivity in Response to Dietary Fat (ed. Circulation) 18 102 Suppl II (2000).
32. Yoshida T. et al. - Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet, 1995, 346, 1433-4; Sakane N. et al. - Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia, 1997, 40, 200-4.
33. Yoshida T. et al. - Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet, 1995, 346, 1433-4; Sakane N. et al. - Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia, 1997, 40, 200-4.
34. Sakane N., Yoshida T., Umekawa T., Kogure A., Kondo, M. - Beta2-adrenoceptor gene polymorphism and obesity. Lancet, 1999, 353, 1976.
35. Luan J. et al. - Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes, 2001, 50, 686-9.
36. Rankinen T. et al. - The human gene map for performance and health-related fitness phenotypes. Med Sci Sports Exerc, 2001, 33, 855-67.
37. Moyna N., Tsongalis G., Meckes C. et al., e. - Apo E Genotype Affects the Increase in Maximal Oxygen Uptake with Exercise Training. Circulation, 2000, 18,
38. Busjahn A., Li G.-H., Faulhaber H. - b-2 adrenergic receptor gene variations and blood pressure under stress in normal twins. Am J Hum Genet, 2000, 67,
39. Corbalan M. S. - The 27Glu polymorphism of the beta2-adrenergic receptor gene interacts with physical activity influencing obesity risk among female subjects. Clin Genet, 2002, 61, 305-7.
40. Hassel C. A., Mensing E. A., Gallaher D. D. - Dietary stearic acid reduces plasma and hepatic cholesterol concentrations without increasing bile acid excretion in cholesterol-fed hamsters. J Nutr, 1997, 127, 1148-55.
41. Hayes K. C. - Synthetic and modified glycerides: effects on plasma lipids. Curr Opin Lipidol, 2001, 12, 55-60.
42. Talmud P. J., Humphries S. E. - Gene: environment interaction in lipid metabolism and effect on coronary heart disease risk. Curr Opin Lipidol, 2002, 13, 149-54.
43. Price P. T., Nelson C. M., Clarke S. D. - Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr Opin Lipidol, 2000, 11, 3-7
44. Tall A. R., Wang N., Mucksavage P. - Is it time to modify the reverse cholesterol transport model? J Clin Invest, 2001, 108, 1273-5; Jump D. B. - Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol, 2002, 13, 155-64.
45. Tall A. R., Wang N., Mucksavage P. - Is it time to modify the reverse cholesterol transport model? J Clin Invest, 2001, 108, 1273-5; Jump D. B. - Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol, 2002, 13, 155-64.